Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 20, 2011 01:49 ET | Source: Evotec AG

Evotec and APEIRON Biologics Start Next Project on the Cbl-b Target

HAMBURG, Germany, Oct. 20, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Apeiron Biologics AG today announced that they have entered into a further discovery project on the...
October 05, 2011 01:48 ET | Source: Evotec AG

Evotec Announces Second Multi-Target Collaboration With UCB

HAMBURG, Germany, Oct. 5, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a second multi year, multi target integrated drug discovery...
September 29, 2011 01:54 ET | Source: Evotec AG

Evotec Acquires Remaining 30% of Indian Joint Venture From DIL

HAMBURG, Germany, Sept. 28, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has signed a Share Purchase Agreement to acquire the remaining 30% of equity of...
September 05, 2011 14:28 ET | Source: Evotec AG

Evotec and Roche Agree to Develop Compound That Could Slow the Progression of Alzheimer's Disease

HAMBURG, Germany, Sept. 5, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Roche AG (SIX:RO, ROG) (OTCQX:RHHBY) announced today that they have entered into an exclusive worldwide...
August 18, 2011 01:33 ET | Source: Evotec AG

Evotec Receives Pre-Clinical Milestone Payment as Part of Its Discovery Alliance With Boehringer Ingelheim

HAMBURG, Germany, Aug. 18, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that its research alliance with Boehringer Ingelheim has achieved a milestone triggering a...
August 11, 2011 01:58 ET | Source: Evotec AG

Evotec Reports 34% Revenue and Profitable Earnings Growth; Revenue Guidance Raised

HAMBURG, Germany, Aug. 11, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the first half of 2011. Strong H1 operational...
August 11, 2011 01:01 ET | Source: Evotec AG

Evotec Partners P2X7 Antagonist Programme, EVT 401, to a Top Tier Global Animal Health Company

HAMBURG, Germany, Aug. 11, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a world-wide license and collaboration agreement with a top tier animal...
August 04, 2011 08:06 ET | Source: Evotec AG

Evotec to Report Second Quarter 2011 Results on 11 August 2011

HAMBURG, Germany, Aug. 4, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) will report its financial results for the second quarter of 2011 on Thursday, 11 August 2011. The Company is going to...
July 07, 2011 01:53 ET | Source: Evotec AG

Evotec Announces Multi-Target Collaboration With UCB in Neurodegenerative and Neurological Diseases

HAMBURG, Germany, July 7, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a three year integrated drug discovery collaboration with UCB to identify...
June 27, 2011 01:57 ET | Source: Evotec AG

Evotec Achieves Milestone in an Ion Channel Drug Discovery Collaboration With Ono Pharmaceutical Co., Ltd.

HAMBURG, Germany, June 27, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced the achievement of specific success criteria in an ion channel research collaboration with Ono...